- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 408638, 6 pages
Reduced T Cell Receptor Excision Circle Levels in the Colonic Mucosa of Microscopic Colitis Patients Indicate Local Proliferation rather than Homing of Peripheral Lymphocytes to the Inflamed Mucosa
1School of Health and Medical Sciences, Örebro University, 70182 Örebro, Sweden
2Division of Gastroenterology, Department of Medicine, Örebro University Hospital, 70185 Örebro, Sweden
3School of Medicine, Örebro University, 70182 Örebro, Sweden
Received 23 April 2013; Revised 20 June 2013; Accepted 24 June 2013
Academic Editor: Tadayuki Oshima
Copyright © 2013 Ashok Kumar Kumawat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. Tysk, J. Bohr, N. Nyhlin, A. Wickbom, and S. Eriksson, “Diagnosis and management of microscopic colitis,” World Journal of Gastroenterology, vol. 14, no. 48, pp. 7280–7288, 2008.
- D. S. Pardi and C. P. Kelly, “Microscopic colitis,” Gastroenterology, vol. 140, no. 4, pp. 1155–1165, 2011.
- A. Munch, D. Aust, J. Bohr, et al., “Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group,” Journal of Crohn's and Colitis, vol. 6, no. 9, pp. 932–945, 2012.
- G. Jarnerot, C. Tysk, J. Bohr, and S. Eriksson, “Collagenous colitis and fecal stream diversion,” Gastroenterology, vol. 109, no. 2, pp. 449–455, 1995.
- S. Brand, “Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease,” Gut, vol. 58, no. 8, pp. 1152–1167, 2009.
- M. Tsuchiya, T. Hibi, M. Watanabe et al., “Thymectomy in ulcerative colitis: a report of cases over a 13 year period,” Thymus, vol. 17, no. 2, pp. 67–73, 1991.
- M. Fritsch Fredin, K. Elgbratt, D. Svensson, L. Jansson, S. Melgar, and E. Hultgren Hörnquist, “Dextran sulfate sodium-induced colitis generates a transient thymic involution—impact on thymocyte subsets,” Scandinavian Journal of Immunology, vol. 65, no. 5, pp. 421–429, 2007.
- K. Elgbratt, M. Bjursten, R. Willén, P. W. Bland, and E. H. Hörnquist, “Aberrant T-cell ontogeny and defective thymocyte and colonic T-cell chemotactic migration in colitis-prone Gαi2-deficient mice,” Immunology, vol. 122, no. 2, pp. 199–209, 2007.
- R. Somech, “T-cell receptor excision circles in primary immunodeficiencies and other T-cell immune disorders,” Current Opinion in Allergy and Clinical Immunology, vol. 11, no. 6, pp. 517–524, 2011.
- M. D. Hazenberg, M. C. Verschuren, D. Hamann, F. Miedema, and J. J. van Dongen, “T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation,” Journal of Molecular Medicine, vol. 79, no. 11, pp. 631–640, 2001.
- T. M. Breit, M. C. M. Verschuren, I. L. M. Wolvers-Tettero, E. J. van Gastel-Mol, K. Hählen, and J. J. M. van Dongen, “Human T cell leukemias with continuous V(D)J recombinase activity for TCR-δ gene deletion,” Journal of Immunology, vol. 159, no. 9, pp. 4341–4349, 1997.
- F. Livak and D. G. Schatz, “T-cell receptor α locus V(D)J recombination by-products are abundant in thymocytes and mature T cells,” Molecular and Cellular Biology, vol. 16, no. 2, pp. 609–618, 1996.
- A. Fischer, S. Hacein-Bey-Abina, and M. Cavazzana-Calvo, “20 years of gene therapy for SCID,” Nature Immunology, vol. 11, no. 6, pp. 457–460, 2010.
- L. Yin, C. A. Rodriguez, W. Hou et al., “Antiretroviral therapy corrects HIV-1-induced expansion of CD8+CD45RA+CD27-CD11abright activated T cells,” Journal of Allergy and Clinical Immunology, vol. 122, no. 1, pp. 166–172, 2008.
- P. P. Tagkalidis, P. R. Gibson, and P. S. Bhathal, “Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile,” Journal of Clinical Pathology, vol. 60, no. 4, pp. 382–387, 2007.
- A. K. Kumawat, H. Strid, K. Elgbratt, C. Tysk, J. Bohr, and E. Hultgren Hörnquist, “Microscopic colitis patients have increased proportions of Ki67+ proliferating and CD45RO+ active/memory CD8+ and CD4+8+ mucosal T cells,” Journal of Crohn's and Colitis, 2012.
- K. Elgbratt, G. Kurlberg, M. Hahn-Zohric, and E. Hultgren Hörnquist, “Rapid migration of thymic emigrants to the colonic mucosa in ulcerative colitis patients,” Clinical and Experimental Immunology, vol. 162, no. 2, pp. 325–336, 2010.
- S. R. Targan, B. G. Feagan, R. N. Fedorak et al., “Natalizumab for the treatment of active Crohn's disease: results of the ENCORE trial,” Gastroenterology, vol. 132, no. 5, pp. 1672–1683, 2007.
- L. Beaugerie and D. S. Pardi, “Review article: drug-induced microscopic colitis—proposal for a scoring system and review of the literature,” Alimentary Pharmacology and Therapeutics, vol. 22, no. 4, pp. 277–284, 2005.
- K. Koetz, E. Bryl, K. Spickschen, W. M. O'Fallon, J. J. Goronzy, and C. M. Weyand, “T cell homeostasis in patients with rheumatoid arthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 9203–9208, 2000.
- F. Ponchel, A. W. Morgan, S. J. Bingham et al., “Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis,” Blood, vol. 100, no. 13, pp. 4550–4556, 2002.
- A. Hug, M. Korporal, I. Schröder et al., “Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis,” Journal of Immunology, vol. 171, no. 1, pp. 432–437, 2003.
- C. Göranzon, A. K. Kumawat, E. Hultgren-Hörnqvist et al., “Immunohistochemical characterization of lymphocytes in microscopic colitis,” Journal of Crohn's and Colitis, 2013.
- A. Münch, J. D. Söderholm, Å. Öst, and M. Ström, “Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment,” American Journal of Gastroenterology, vol. 104, no. 3, pp. 679–685, 2009.
- J. Bohr, R. Nordfelth, G. Järnerot, and C. Tysk, “Yersinia species in collagenous colitis: a serologic study,” Scandinavian Journal of Gastroenterology, vol. 37, no. 6, pp. 711–714, 2002.
- A. K. Kumawat, H. Strid, C. Tysk, J. Bohr, and E. H. Hornquist, “Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile,” Molecular Immunology, vol. 55, no. 3-4, pp. 355–364, 2013.
- C. Martinez, A. Gonzalez-Castro, M. Vicario, and J. Santos, “Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome,” Gut Liver, vol. 6, no. 3, pp. 305–315, 2012.
- C. Cremon, L. Gargano, A. M. Morselli-Labate et al., “Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms,” American Journal of Gastroenterology, vol. 104, no. 2, pp. 392–400, 2009.
- V. S. Chadwick, W. Chen, D. Shu et al., “Activation of the mucosal immune system in irritable bowel syndrome,” Gastroenterology, vol. 122, no. 7, pp. 1778–1783, 2002.